Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
Oncolytic Semliki Forest virus (SFV) has been suggested as a potential candidate for the treatment of glioblastoma and neuroblastoma. However, the oncolytic capacity of SFV is restricted by the anti-viral type-I interferon (IFN) response. The aim of this study was to increase the oncolytic capacity...
Main Authors: | Tina Sarén, Mohanraj Ramachandran, Miika Martikainen, Di Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770517300451 |
Similar Items
-
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
by: Miika Martikainen, et al.
Published: (2021-06-01) -
Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
by: Jing Ma, et al.
Published: (2021-06-01) -
Control of the rescue and replication of Semliki Forest virus recombinants by the insertion of miRNA target sequences.
by: Kaspar Ratnik, et al.
Published: (2013-01-01) -
Cancer Immunotherapy : Evolving Oncolytic viruses and CAR T-cells
by: Ramachandran, Mohanraj
Published: (2016) -
Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ
by: Baiba Kurena, et al.
Published: (2017-11-01)